Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statement of the problem.

George Steiner1,

  • 1University of Toronto and Toronto General Hospital, Toronto, Ontario, Canada. george.steiner@uhn.on.ca

The American Journal of Cardiology
|July 4, 2006
PubMed
Summary

The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) study investigated optimal treatments for type 2 diabetes mellitus. It compared strategies for hyperglycemia and coronary artery disease management to reduce cardiovascular events and mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier.

Scientific reports·2019
Same author

Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier.

Oncotarget·2018
Same author

Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair.

Scientific reports·2017
Same author

Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.

Atherosclerosis·2016
Same author

Appropriate revascularization in stable angina: lessons from the BARI 2D trial.

The Canadian journal of cardiology·2014
Same author

How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD.

Cardiovascular drugs and therapy·2009

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular disease (CVD) risk.
  • Hyperglycemia management in T2DM requires careful consideration of treatment strategies.
  • Coronary artery disease (CAD) in diabetic patients presents complex management challenges.

Purpose of the Study:

  • To determine the optimal approach for managing hyperglycemia in T2DM to reduce death or major adverse cardiovascular events.
  • To compare the effectiveness of medical versus interventional treatments for coronary artery disease in patients with diabetes.

Main Methods:

  • The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) study enrolled patients with T2DM and CAD.
  • Investigated two primary questions regarding T2DM and CAD management.
  • Compared strategies for correcting insulin deficiency versus reducing insulin resistance for hyperglycemia.

Main Results:

  • The study aimed to answer critical questions about T2DM and CAD management.
  • Results will inform clinical decisions for diabetic patients with cardiovascular complications.
  • Detailed findings on treatment efficacy are presented in the full study.

Conclusions:

  • The BARI 2D study provides crucial insights into managing complex T2DM and CAD.
  • Findings guide therapeutic choices to improve outcomes for diabetic patients at high cardiovascular risk.
  • Evidence-based recommendations for hyperglycemia and CAD treatment strategies are derived from this research.

Related Experiment Videos